Related Experiment Video
Updated: May 5, 2026
06:57
Development of an Antigen-driven Colitis Model to Study Presentation of Antigens by Antigen Presenting Cells to T Cells
Published on: September 18, 2016
8.4K
Evolving treatment strategies for inflammatory bowel disease
1Department of Medicine, Section of Gastroenterology, University of Chicago, Chicago, Illinois, USA. shanauer@medicine.bsd.uchicago.edu
Annual Review of Medicine
|February 13, 2001
Summary
Newer therapies for Crohn
Area of Science:
- Gastroenterology and immunology.
Background:
- Crohn's disease and ulcerative colitis are inflammatory bowel diseases (IBD) stemming from immune dysregulation in susceptible individuals.
- Current IBD treatments aim to induce or maintain remission, balancing efficacy with complication management.
Purpose of the Study:
- To review advancements in IBD therapy, focusing on novel approaches and their integration with conventional treatments.
- To highlight the potential of targeted immunoinflammatory pathways in modifying IBD's natural course.
Main Methods:
- Review of current and emerging therapeutic strategies for inflammatory bowel diseases.
- Analysis of safety and efficacy data for conventional and novel treatment modalities.
- Focus on immunoinflammatory pathway targets.
Main Results:
- Novel therapeutic approaches enhance the safety and efficacy of conventional IBD treatments.
- Targeting specific immunoinflammatory pathways is crucial for improved outcomes.
- Combination therapy shows promise in altering the disease trajectory.
Conclusions:
- Integrated conventional and novel therapies offer a more effective strategy for managing Crohn's disease and ulcerative colitis.
- Future IBD management may involve personalized approaches targeting specific immune pathways.
- These advancements hold the potential to significantly modify the long-term prognosis of IBD.
Related Concept Videos
01:29Drugs for Treatment of Ulcerative Colitis in IBD
721
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
721
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
780
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
780
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
703
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
703
01:30Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
1.1K
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
1.1K
01:29Inflammatory Bowel Disease IV: Pharmacological Management
1.1K
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
1.1K
01:21Inflammatory Bowel Disease V: Surgical Management
926
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
926